Logo image of MDWD

MEDIWOUND LTD (MDWD) Stock Overview

NASDAQ:MDWD - IL0011316309 - Common Stock

16.6 USD
-0.1 (-0.6%)
Last: 9/2/2025, 4:30:02 PM
16.6 USD
0 (0%)
After Hours: 9/2/2025, 4:30:02 PM

MDWD Key Statistics, Chart & Performance

Key Statistics
52 Week High22.51
52 Week Low14.14
Market Cap180.61M
Shares10.88M
Float8.06M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.64
PEN/A
Fwd PEN/A
Earnings (Next)11-24 2025-11-24
IPO03-20 2014-03-20
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


MDWD short term performance overview.The bars show the price performance of MDWD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

MDWD long term performance overview.The bars show the price performance of MDWD in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of MDWD is 16.6 USD. In the past month the price decreased by -9.64%.

MEDIWOUND LTD / MDWD Daily stock chart

MDWD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.52 695.83B
JNJ JOHNSON & JOHNSON 17.81 428.83B
NVO NOVO-NORDISK A/S-SPONS ADR 14.38 250.52B
AZN ASTRAZENECA PLC-SPONS ADR 18.06 248.63B
NVS NOVARTIS AG-SPONSORED ADR 14.31 245.16B
MRK MERCK & CO. INC. 11.1 213.51B
PFE PFIZER INC 7.37 142.03B
SNY SANOFI-ADR 11.14 120.92B
BMY BRISTOL-MYERS SQUIBB CO 7.04 96.50B
GSK GSK PLC-SPON ADR 8.6 78.49B
ZTS ZOETIS INC 24.58 67.75B
TAK TAKEDA PHARMACEUTIC-SP ADR 52.28 47.88B

About MDWD

Company Profile

MDWD logo image MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Company's portfolio is focused on next-generation protein-based therapies for burn and wound care and tissue repair and includes products such as, NexoBrid, a concentrate of proteolytic enzymes enriched in bromelain, which is an easy to use, topically-applied product that removes eschar in four hours without harming the surrounding healthy tissues. ; EscharEx biological drug candidate for the debridement of chronic and other hard-to-heal wounds; MW005 a topically applied biological drug candidate for the treatment of non-melanoma skin cancers, based on the same API of NexoBrid and EscharEx products, a concentrate of proteolytic enzymes enriched in bromelain.

Company Info

MEDIWOUND LTD

42 Hayarkon Street

YAVNE 8122745 IL

CEO: Sharon Malka

Employees: 111

MDWD Company Website

MDWD Investor Relations

Phone: 972779714100

MEDIWOUND LTD / MDWD FAQ

What is the stock price of MEDIWOUND LTD today?

The current stock price of MDWD is 16.6 USD. The price decreased by -0.6% in the last trading session.


What is the ticker symbol for MEDIWOUND LTD stock?

The exchange symbol of MEDIWOUND LTD is MDWD and it is listed on the Nasdaq exchange.


On which exchange is MDWD stock listed?

MDWD stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for MEDIWOUND LTD stock?

12 analysts have analysed MDWD and the average price target is 31.28 USD. This implies a price increase of 88.43% is expected in the next year compared to the current price of 16.6. Check the MEDIWOUND LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is MEDIWOUND LTD worth?

MEDIWOUND LTD (MDWD) has a market capitalization of 180.61M USD. This makes MDWD a Micro Cap stock.


How many employees does MEDIWOUND LTD have?

MEDIWOUND LTD (MDWD) currently has 111 employees.


What are the support and resistance levels for MEDIWOUND LTD (MDWD) stock?

MEDIWOUND LTD (MDWD) has a support level at 15.78 and a resistance level at 18.34. Check the full technical report for a detailed analysis of MDWD support and resistance levels.


Is MEDIWOUND LTD (MDWD) expected to grow?

The Revenue of MEDIWOUND LTD (MDWD) is expected to grow by 18.48% in the next year. Check the estimates tab for more information on the MDWD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy MEDIWOUND LTD (MDWD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does MEDIWOUND LTD (MDWD) stock pay dividends?

MDWD does not pay a dividend.


When does MEDIWOUND LTD (MDWD) report earnings?

MEDIWOUND LTD (MDWD) will report earnings on 2025-11-24.


What is the Price/Earnings (PE) ratio of MEDIWOUND LTD (MDWD)?

MEDIWOUND LTD (MDWD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.64).


What is the Short Interest ratio of MEDIWOUND LTD (MDWD) stock?

The outstanding short interest for MEDIWOUND LTD (MDWD) is 9.94% of its float. Check the ownership tab for more information on the MDWD short interest.


MDWD Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

MDWD Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to MDWD. MDWD may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

MDWD Financial Highlights

Over the last trailing twelve months MDWD reported a non-GAAP Earnings per Share(EPS) of -2.64. The EPS decreased by -22.22% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -41.72%
ROE -138.93%
Debt/Equity 0.4
Chartmill High Growth Momentum
EPS Q2Q%-80.88%
Sales Q2Q%12.74%
EPS 1Y (TTM)-22.22%
Revenue 1Y (TTM)-1.42%

MDWD Forecast & Estimates

12 analysts have analysed MDWD and the average price target is 31.28 USD. This implies a price increase of 88.43% is expected in the next year compared to the current price of 16.6.

For the next year, analysts expect an EPS growth of 24.52% and a revenue growth 18.48% for MDWD


Analysts
Analysts83.33
Price Target31.28 (88.43%)
EPS Next Y24.52%
Revenue Next Year18.48%

MDWD Ownership

Ownership
Inst Owners35.7%
Ins Owners1.68%
Short Float %9.94%
Short Ratio10.78